Why the Slater & Gordon Limited share price just hit a record low

Shares in Slater & Gordon Limited (ASX:SGH) keep falling.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Slater & Gordon Limited (ASX: SGH) closed at a record low of 21 cents today as holders continue to dump the stock due to the group's debt mountain and recent admission that it is exploring options to recapitalise or refinance itself.

If a company is seeking to recapitalise itself any new lender or financier is going to require very attractive terms that are likely to be to the detriment of existing shareholders.

Therefore, the share price will probably remain under selling pressure until the company can either demonstrate a strong swing to positive cash flows, or announce some sort of debt restructure involving an extension to its terms to maturity. An extension to the debt maturity profile is probably top of the agenda as it's hard to see a new lender throwing funds at Slater & Gordon which means it's now reliant on the largesse of its creditors as a capital raising doesn't look an option given the current market value.

Events may come to a head by the end of February when the company will be forced to reveal its latest cash flow statements after an operating cash loss of $104.2 million last year. On top of this it had a gross debt pile of $765 million at the end of financial year 2016, which suggests it will be under almighty pressure to deliver positive cash flows over H1 2017.

If it doesn't it's possible to speculate that its creditors (some of whom have bought its debt for just 45 cents in the dollar) may be in a position to move to force a restructure that could spell disaster for ordinary shareholders.

Needless to say buying Slater & Gordon shares looks a dim idea, especially when you consider there are so many other profitable companies paying big dividend yields that you could buy instead….

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »